Pfizer seeking approval to use COVID pill to treat children

February 9, 2022 6:09 AM

Published February 9, 2022 6:20 AM

(KYMA, KECY) - Pfizer is working to get its COVID-fighting pill used in more people.

Paxlovid is currently authorized to treat COVID-19 in high-risk people 12-year-old and older.

Pfizer is planning to study the drug in children aged six to 18 starting sometime this quarter.

The pharmaceutical giant is also awaiting full approval from the Food and Drug Administration on the pill for the groups it is currently authorized to treat.

The company says it expects that decision in the second half of this year.

Article Topic Follows: Coronavirus

Jump to comments ↓

April Hettinger

April was born and raised in San Diego where she loved the beach town and her two dogs, Lexi and Malibu. She decided to trade the beach for the snow and advanced her education at Northern Arizona University in Flagstaff.

BE PART OF THE CONVERSATION

KYMA KECY is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.